treatment with oral ciprofloxacin should offer substantial cost savings over a variety of parenteral antimicrobial regimens ( e.g . aminoglycoside + beta-lactams ) for difficult to treat infections such as chronic pyelonephritis , osteomyelitis , and skin structure infections .
C0008809
ciprofloxacin
C1136254
antimicrobial